Iconlab Inc. v. Valeant Pharm. Int'l, Inc. (In re Malyugin)

310 F. Supp. 3d 3
Court of Appeals for the D.C. Circuit·Decided April 17, 2018·No. Case No. 1:18–mc–00049 (TNM); Case No. 8:16–cv–01321–LJS–KES·Published·Cited by 2 cases

Opinion

TREVOR N. MCFADDEN, United States District Judge

Dr. Boris Malyugin, a Russian national, seeks to quash a third-party subpoena served on him on April 15, 2018 noticing a deposition and the production of documents for April 17, 2018. Mem. in Supp. of Emergency Mot. to Stay and Quash Third-Party Subpoena ("Mot. to Quash")

*52, 8, ECF No. 1-1. Because the subpoena was served two days prior to the deposition, and compliance will require Dr. Malyugin to travel more than 100 miles from where he resides, is employed, or regularly transacts business in person, the motion to quash is granted. See Fed. R. Civ. P. 45(d)(3)(A)(i)-(ii). This Order is issued without prejudice for the parties seeking the testimony and evidence to re-serve Dr. Malyugin with a subpoena in compliance with Rule 45.

In November 2016, Dr. Malyugin executed a declaration in the ongoing matter of Iconlab Inc. et al. v. Valeant Pharms. Int'l, Inc. et al. , 8:16-cv-01321, in the United States District Court for the Central District of California. Defs.' Opp. to Mot. to Quash ("Defs.' Opp") Ex. 5, ECF No. 2-6. The Second Amended Complaint, the operative Complaint, identifies Dr. Malyugin by name a multitude of times and seems to incorporate the information contained in Dr. Malyugin's declaration. See id. Ex. 4, ECF No. 2-5. Because of this, several defendants (the "Defendants") in the underlying litigation sought, starting on March 22, 2018, to depose Dr. Malyugin and sent him and the plaintiffs in the underlying litigation a series of communications about his deposition. Defs.' Opp. 6-7. Dr. Malyugin did not respond to these communications. Id. Once the Defendants learned that Dr. Malyugin was scheduled to be in the United States-more specifically, in the District of Columbia-for the annual meeting of the American Society of Cataract and Refractive Surgery and the American Society of Ophthalmic Administrators (to be held April 13, 2018 to April 17, 2018), the Defendants executed and served Dr. Malyugin with a subpoena noticing his deposition for April 17, 2018. Defs.' Opp. 7-8; Mot. to Quash 1-2.

Rule 45(d)(3)(A) requires a court to "quash or modify a subpoena that (i) fails to allow a reasonable time to comply; (ii) requires a person who is neither a party nor a party's officer to travel more than 100 miles from where that person resides, is employed, or regularly transacts business in person [with one exception not relevant here]; (iii) requires disclosure of privileged or other protected matter ...; or (iv) subjects a person to undue burden." Subparts (i) and (ii) are relevant here. The subpoena was served on Dr. Malyugin on April 15, 2018, two days prior to the date of compliance. Two days' notice is plainly unreasonable. See, e.g., Judicial Watch, Inc. v. U.S. Dep't of Commerce , 34 F.Supp.2d 47, 49-50 (D.D.C.1998) (witness entitled to object to a subpoena served one or two days before the scheduled deposition); Rules of the United States District Court for the District of Columbia Civil Rule 30.1 ("Service of a deposition seven days in advance of the date set for taking the deposition shall constitute 'reasonable notice' to a party as required by Fed. R. Civ. P. 30(b)"). Though the Defendants made good faith efforts to seek discovery from Dr. Malyugin through email and other communications as early as March 22, 2018, service was not made until April 15, 2018. Unfortunately for the Defendants, attempted service or negotiations to effect service are insufficient. The primary case cited by both parties, Brown v. Hendler , 2011 WL 321139 at *2 (S.D.N.Y. Jan. 31, 2011), involved a scenario where the potential witness was served with nine days to comply. See Mot. to Quash 6; Defs.' Opp. 9-10. The district court in that case noted that "many courts have found fourteen dates from the date of service as presumptively reasonable." Id. (emphasis added). Thus, the subpoena fails to allow a reasonable time to comply. See Fed. R. Civ. P. 45(d)(3)(A)(i).

While Dr. Malyugin is presently in the District of Columbia and therefore would not currently need to "travel more than 100 miles from where that person resides, *6is employed, or regularly transactions business in person [in this case, the Russia Federation]," his stay in the District of Columbia is temporary. See Mot. to Quash 1-2 (the annual meeting for which Dr. Malyugin is in the District of Columbia ends on April 17, 2018). It is apparently uncontested that he lives and works in Russia. See generally Defs.' Opp. In light of Rule 45(d)(3)(A)(i)'s requirement that a subpoena provide a reasonable amount of time to comply, re-noticing the deposition with a reasonable timeframe for compliance may then violate Rule 45(d)(3)(A)(ii)'s geographical constriction.

Free access — add to your briefcase to read the full text and ask questions with AI

Iconlab Inc. v. Valeant Pharm. Int'l, Inc. (In re Malyugin), 310 F. Supp. 3d 3 (D.C. Cir. 2018).

310 F. Supp. 3d 3 (Iconlab Inc. v. Valeant Pharm. Int'l, Inc. (In re Malyugin)) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

McCabe v. Albright
District of Columbia, 2024
Catherine Trinh
C.D. California, 2022